D&A
Flow – sum over the period · $M
Q4 FY2021
0.7a$M
derived
All values (23)
| Period | Value ($M) | Status |
|---|---|---|
| Q1 FY2027 | 8.6 | reported |
| Q4 FY2026 | 15.9 | derived |
| Q3 FY2026 | 6.7 | reported |
| Q2 FY2026 | 6.5 | reported |
| Q1 FY2026 | 5.5 | reported |
| Q4 FY2025 | 7.7 | derived |
| Q3 FY2025 | 5.1 | reported |
| Q2 FY2025 | 5.0 | reported |
| Q1 FY2025 | 4.2 | reported |
| Q4 FY2024 | 3.7 | derived |
| Q3 FY2024 | 3.4 | reported |
| Q2 FY2024 | 3.7 | reported |
| Q1 FY2024 | 3.0 | reported |
| Q4 FY2023 | 3.0 | derived |
| Q3 FY2023 | 2.3 | reported |
| Q2 FY2023 | 2.6 | reported |
| Q1 FY2023 | 1.6 | reported |
| Q4 FY2022 | 1.5 | derived |
| Q3 FY2022 | 1.3 | reported |
| Q2 FY2022 | 1.1 | reported |
| Q1 FY2022 | 0.9 | reported |
| Q4 FY2021 | 0.7 | derived |
| Q3 FY2021 | 0.6 | reported |
22 periods without value hidden · Show gaps with reason · CSV with all sources · Technical ID: dna
More metrics for Credo
Income statement
Balance sheet
Sources & calculation
- Value
- 672,000 USD (derived)
- Period
- Q4 FY2021, ended Apr 30, 2021 · quarterly value (3 months, not cumulative)
- Calculation
- Q4 = fiscal year − 9 months cumulative = 2M − 2M = $1.0M (FY value from 10-K 0001628280-22-016593; 9-month value from the Q3-10-Q)
- Source
- 10-K, filed Jun 8, 2022 · 0001628280-22-016593
- Location
- us-gaap:DepreciationDepletionAndAmortization
- Confidence
- 1. – directly from an XBRL fact in the filing (or calculated exactly from it)
Versions
| v1 | 672,000 USD | Jun 8, 2022 | 10-K 0001628280-22-016593 | derived · confidence 1. · current |